← Leaderboards
W A Brzezinski
Medical University Of South Carolina
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 2
By mechanism
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Norman H Bell$1,281,695
- B Hildreth$0
- Diane L Kamen$6,427,107
- Bruce W Hollis$5,412,543
- Sebastiano Gattoni-Celli$697,316
Others in their field
Top investigators on “Women'S Health”
- Chanza Baytop · Westat, Inc.$271,217,917
- Wafaa M. El-Sadr · Columbia University Health Sciences$240,499,512
- Sharon A Nachman · Johns Hopkins University$213,337,729
- Myron S Cohen · Family Health International$206,489,087
- Barbara Driver · Westat, Inc.$200,651,985
- Carol Nesel · Westat$188,148,170
Research focus
Women'S HealthClinical ResearchDrug Adverse EffectDrug Screening /EvaluationFemaleHuman SubjectHuman Therapy EvaluationPostmenopauseSkeletal Disorder ChemotherapyAlendronateOsteoporosisPlacebosBone DensityCalcitoninVitamin DDietary CalciumDosage FormsDrug Administration Rate /DurationLongitudinal Human StudyOral AdministrationDrug Tolerance
Grant awards (8)
ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2002 · RR
ALENDRONATE, MIACALCIN IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2002 · RR
ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
ALENDRONATE, MIACALCIN IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
ALENDRONATE, MIACALCIN IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
ALENDRONATE, MIACALCIN IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
ALENDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR